Rudolph Carsten, Schillinger Ulrike, Ortiz Aurora, Plank Christian, Golas Monika M, Sander Bjoern, Stark Holger, Rosenecker Joseph
Department of Pediatrics, Ludwig-Maximilians University, 80337 Munich, Germany.
Mol Ther. 2005 Sep;12(3):493-501. doi: 10.1016/j.ymthe.2005.03.002.
The lung is an important target of gene therapeutic interventions. In contrast to intratracheal instillation, inhalation would be the most practical route of administration in clinical applications. Here we show that aerosolized nanogram quantities of pDNA complexed to PEI (350 ng) yielded transfection levels 15-fold higher than a 140-fold higher dose (50 microg) of the same vector applied directly to the lungs of mice via intratracheal intubation. An important efficacy parameter is the osmolarity of the aerosol and not biophysical properties of the nebulized vector. Vectors formulated and nebulized in hypoosmotic distilled water yielded 57- and 185-fold higher expression levels than those in isotonic 5% glucose or Hepes-buffered saline, respectively. Pretreatment of mice with nebulized indomethacin, which prevents water-induced airway alteration, resulted in lower gene expression, whereas pretreatment with EGTA or polidocanol, which modulate tight-junction activity, had no effect. These results, together with histological analysis of regional lung deposition and gene expression, suggest that a temporary water-induced hypoosmotic shock permeabilizes the epithelium sufficiently to allow vector uptake. The so far observed inefficiency of nonviral gene delivery to the airways may be the result of an inappropriate method of vector administration.
肺是基因治疗干预的重要靶点。与气管内滴注相比,吸入法在临床应用中将是最实用的给药途径。在此我们表明,雾化的与聚乙烯亚胺(PEI)复合的纳克量的质粒DNA(350纳克)产生的转染水平比通过气管插管直接应用于小鼠肺部的相同载体的高140倍剂量(50微克)高15倍。一个重要的疗效参数是气雾剂的渗透压,而不是雾化载体的生物物理性质。在低渗蒸馏水中配制和雾化的载体分别产生比等渗5%葡萄糖或赫佩斯缓冲盐水中高57倍和185倍的表达水平。用雾化的消炎痛预处理小鼠可防止水诱导的气道改变,导致基因表达降低,而用调节紧密连接活性的乙二醇双乙胺醚(EGTA)或聚多卡醇预处理则没有效果。这些结果,连同对肺局部沉积和基因表达的组织学分析,表明暂时的水诱导的低渗休克使上皮充分通透以允许载体摄取。迄今为止观察到的非病毒基因递送至气道的低效率可能是载体给药方法不当的结果。